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Abstract
Tumor necrosis factor a (TNF-a)is a host inflammatory factor. Bacteria increase TNF-a expression in a variety of
human diseases including infectious diseases, inflammatory bowel diseases, and cancer. It is unknown, however,
how TNF-a directly modulates bacterial protein expression during intestinal infection and chronic inflammation. In
the current study, we hypothesize that Salmonella typhimurium senses TNF-a and show that TNF-a treatment
modulates Salmonella virulent proteins (called effectors), thus changing the host-bacterial interaction in intestinal
epithelial cells. We investigated the expression of 23 Salmonella effectors after TNF-a exposure. We found that TNF-
a treatment led to differential effector expression: effector SipA was increased by TNF-a treatment, whereas the
expression levels of other effectors, including gogB and spvB, decreased in the presence of TNF-a. We verified the
protein expression of Salmonella effectors AvrA and SipA by Western blots. Furthermore, we used intestinal epithe-
lial cells as our experimental model to explore the response of human intestinal cells to TNF-a pretreated Salmo-
nella. More bacterial invasion was found in host cells colonized with Salmonella strains pretreated with TNF-a
compared to Salmonella without TNF-a treatment. TNF-a pretreated Salmonella induced higher proinflammatory
JNK signalling responses compared to the Salmonella strains without TNF-a exposure. Exposure to TNF-a made
Salmonella to induce more inflammatory cytokine IL-8 in intestinal epithelial cells. JNK inhibitor treatment was able
to suppress the effects of TNF-pretreated-Salmonella in enhancing expressions of phosphorylated-JNK and c-jun
and secretion of IL-8. Overall, our study provides new insights into Salmonella-host interactions in intestinal
inflammation.
Background
Tumor necrosis factor a(TNF-a)is a pleiotropic inflam-
matory cytokine with increased expression in many
human diseases. These diseases include septic shock,
cancer, AIDS, multiple sclerosis, diabetes, rheumatoid
arthritis, and inflammatory bowel disease [1-6]. It is well
documented that multiple factors from bacteria, viruses,
and parasites stimulate production of TNF-a in the host
[7-10]. Hence, in hosts with inflammatory diseases,
enteric bacteria are potentially exposed to high levels of
TNF-a.
Bacteria can sense signal molecules secreted by their
hosts. This communication mechanism between
bacterium is called “quorum sensing” (QS) [11,12]. QS
utilizes hormone-like compounds referred to as autoin-
ducers to regulate bacterial gene expression [13,14]. QS
also applies to the communication between the host and
bacteria [11]. However, it is unknown how TNF-a from
host cells directly modulates bacterial protein expression
during infection and chronic inflammation.
Salmonella is a leading cause of gastrointestinal dis-
ease worldwide. Salmonella uses the type three secretion
system (TTSS), a needle-like protein transport device to
inject virulence proteins into eukaryotic host cells.
These virulence factors, called effectors, paralyze or
reprogram the eukaryotic cell to the benefit of the
pathogen [15-17]. The activity of TTSS effectors allows
bacteria to invade non-phagocytic cells or inhibit phago-
cytosis, regulate pro-inflammatory responses, prevent
autophagy, or modulate intracellular trafficking [18].
Salmonella effectors display a large repertoire of
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biochemical activities and modulate the function of cru-
cial host regulatory molecules[19-22].
Effectors are encoded via specific pathogenicity island
1 (SPI-1) and 2 (SPI-2). Over 30 Salmonella effectors,
including AvrA, SipA, SipB, Gog B, and SpVB, have
been shown to manipulate a succession of key signaling
transduction pathways and physiological functions of
host cells [19]. AvrA, SipA, SipB, SopB, SopD, SopE,
SopE2 are SPI-1 effectors. SipA, SipB, SopB, SopD,
SopE, SopE2 and other effectors are known to induce
membrane deformation and ruffling that triggers bacter-
ial internalization, promoting invasion [19,23,24]. The
SPI-2 effectors, such as Gog B and SpVB, promote bac-
terial replication and systemic spread [19-22]. Recent
studies indicate that there may be interplay between
SPI-1 and SPI-2 effectors [19]. Although Salmonella is
one of the best characterized pathogens, it remains
unknown how virulence effector gene expression
changes in response to host factors, such as TNF-a.
In Salmonella strains, AvrA is an acid-inducible effec-
tor that is strongly correlated with food hygiene and
food-borne infection [25-27]. Our publications and
others’ have demonstrated that AvrA is a multifunc-
tional protein that plays a critical role in inhibiting
inflammation, regulating epithelial apoptosis, and enhan-
cing proliferation during bacterial infection [28-32]. Sti-
mulation of inflammation by effectors is crucial for
Salmonella to grow in the intestine [33]. Effectors, such
as SipA, SopE, and SopB, are known to activate inflam-
mation in host cells [24,34-41]. Un-controlled inflamma-
tion is harmful to the host, however, and eventually
damages the niche occupied by Salmonella during infec-
tion. Salmonella secreted factor L (SseL) [42-44], SspH
1 [45], SptP, and AvrA may reverse the activation of sig-
naling pathways induced by other Salmonella effectors
[19,46,47].
Intestinal epithelial cells are physically linked by inter-
cellular junctional complexes that regulate multiple
functions including polarity, mechanical integrity, and
signaling capacity [48]. Salmonella can invade and repli-
cate within intestinal epithelial cells during the infection
process [49]. Nontyphoidal Salmonella serotypes such as
Salmonella typhimurium provoke an intense intestinal
inflammatory response, consisting largely of neutrophil
migration across the epithelial lining of the intestine
[50,51]. Studies of S. typhimurium-infected laboratory
animals and cultured epithelial cells have shown that
bacteria rapidly enter epithelial cells after transient
degeneration of the host cell surface microvilli and
induce inflammatory responses [52-58]. Not surprisingly,
the ability of S. typhimurium to enter epithelial cells
constitutes a crucial step in pathogenesis. Salmonella
invasion of the intestinal epithelium requires the viru-
lence-associated TTSS [19,28,34,53,59]. Within the host
intestine specialized antigen-sampling M cells, which
reside in the epithelium overlying lymphoid tissues in
the gut, are a preferred site of Salmonella invasion [60].
The factors involved in Salmonella-M cell interactions,
however, are not well understood. Clearly, studying
effectors can uncover important mechanisms of regula-
tion in host-bacteria interaction.
A recent study demonstrated that Salmonella gastro-
enteritis increases short- and long-term risk of inflam-
matory bowel disease [61]. Chronic intestinal
inflammation enhances TNF-a levels in the host [62].
Therefore, enteric Salmonella is potentially exposed to
TNF-a. In the current study, we hypothesize that Sal-
monella senses the host inflammatory factor TNF-a and
that TNF-a treatment modulates Salmonella TTSS
effectors, thus changing the host-bacteria interaction.
We investigated the gene expression of Salmonella
effectors changed by TNF-a and responses of the
human intestinal cells to TNF-a treated Salmonella. We
verified the expression levels of some effector proteins
by Western blots. Furthermore, we used human intest-
inal epithelial cells as our experimental model to explore
bacterial invasion and the proinflammatory NF-B and
c-Jun N-terminal kinase (JNK) signaling pathways in
response to Salmonella strains with or without TNF-a
pre-treatment. We found that TNF-a treatment modu-
lated effector expression in a differentiated manner. Sal-
monella strains pre-treated with TNF-a induced more
bacteria internalization and a more severe inflammatory
response in intestinal epithelial cells than untreated Sal-
monella strains. Our study provides new insights into
host factor regulation of bacterial effector expression
through inflammatory responses.
Materials and methods
Bacterial strains and growth conditions
Salmonella strains (listed in Table 1) include wild-type
(WT), S. typhimurium ATCC 14028s, S. typhimurium
PhoPC [63], Salmonella typhimurium 1344 (SL1344),
and an AvrA mutant strain lacking the AvrA gene
(SL1344AvrA-) (provided by Dr. Jorge Galan from
Yale University) [25]. Wild-type S. typhimurium 14028s
AvrA - was generated in our laboratory based on pre-
viously published methods by Hamilton et al., and
Miller et al. [64,65]. Briefly, the AvrA gene, flanked by
upstream and downstream Salmonella chromosome
sequences, was cloned into pMAK705 (chloramphenicol
resistant). The construct plasmid was transformed into
the Salmonella WT14028s strain by electroporation
with a Gene Pulser apparatus (Bio-Rad, Munich, Ger-
many) and grown at 30°C on chloramphenicol plates.
Resulting colonies were then grown at 42°C to select for
integrants. The integrants were subsequently grown at
30°C, the temperature at which the plasmid can leave
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the chromosome and autonomously replicate. AvrA
gene deletion was screened by PCR. AvrA deletion was
also verified by Western blot using the anti-AvrA anti-
body. The resulting strain was named SL14028s AvrA-.
Bacteria were grown under the following conditions:
non-agitated microaerophilicbacterial cultures were pre-
pared by inoculation of 10 ml of Luria-Bertani broth
with0.01 ml of a stationary phase culture with or with-
out TNF-a (10 ng/ml), followed by overnight incubation
(~18 h) at 37°C, as previously described [53]. Overnight
cultures of bacteria were concentrated 33-fold in Hank’s
balanced salt solution (HBSS) supplemented with 10
mM HEPES, pH 7.4. The overnight cultures from the
TNF-a pretreated Salmonella strains were washed thor-
oughly with HBSS 3 times to get rid of potential TNF-a
residue in the media. The bacteria were then resus-
pended in fresh HBSS for cell lysis or colonization in
the intestinal epithelial cells.
Reverse transcription polymerase chain reaction (RT-PCR)
Total RNA was extracted from bacteria using a Qiagen
RNeasy mini kit (Cat: 74104. Qiagen, Valencia, CA)
according to the manufacturer’s protocol. Total RNA
was further digested with DNase I (Cat: 18068-015. Invi-
trogen, Carlsbad, CA, USA). RNA integrity was verified
by gel electrophoresis. Extracted RNA yield and purity
was then determined by measuring absorbance in the
220 nm to 350 nm range. From the resulting spectra,
the concentration of nucleic acids was estimated using
the absorbance values at 260 nm, while the purity of
each sample was determined by calculating the 260/280
and 260/230 ratios. RNA reverse transcription was per-
formedusing a SuperScript III kit (Invitrogen, Cat:
18080-051)according to the manufacturer’s directions.
cDNA reactionproducts were then used in a quantitative
PCR reaction. The reaction mixture was subjected to 29
cycles of PCR amplification using Taq polymerase (Fer-
mentas, Glen Burnie, Maryland. Cat: EP0404). All PCR
primers (Table 2) were designedusing Lasergene soft-
ware (DNAStar, Madison, WI). PCR products were
separated on 2% agarose gels and densitometry readings
of the DNA bands were taken using a Kodak IS2000R.
The densitometry value of each PCR band was detected
using KODAK MI 4.0.3. All expressionlevels were
normalized to the bacterial reference gene, Mdh, of the
same sample, using forward (5′-ATGAAAGTCG-
CAGTCCTCGGCGCTGCTGGCGG-3′) and reverse (5′-
ATATCTTTYTTCAGCGTATCCAGCAT-3′)primers
for malate dehydrogenase (Mdh) [66]. All PCR reac-
tionswere performed in triplicate. The digital images are
representative of the original data.
Immunoblotting for bacterial SipA and AvrA
Bacteria were lysed in lysis buffer (50 mM Tris, pH 6.8,
100 mM dithiothreitol, 2% SDS, 0.1%bromophenol blue,
10% glycerol) and sonicated. Equal amounts of total pro-
teins were loaded, separated by SDS-PAGE, and pro-
cessed for immunoblotting with an anti-SipA antibody
(generated by Dr. Ho-Young Kang, Pusan National Uni-
versity, Korea) or anti-AvrA antibody. For the anti-AvrA
antibody, a 15-amino-acid peptide CGEEPFLPSDKA-
DRY was designed based on AvrA amino acids 216-230.
Two rabbits were injected with the peptide and a poly-
clonal antibody for AvrA was tested and purified, as
previously described [30]. Immunoblotting was visua-
lized by enhanced chemi-luminescence (ECL). Chemi-
luminescent signals were collected and scanned from
ECL Hyperfilm (Amersham Pharmacia Biotech) with a
Scanjet 7400c backlit flatbed scanner (Hewlett-Packard
Co., Palo Alto, CA). Bands were quantified using Kodak
MI software (v.4.0.3). The digital images are representa-
tive of the original data.
Intestinal epithelial cell culture
Human colonic epithelial HCT116 cells (American Type
Culture Collection, Manassas, VA) were grown in
DMEM (high glucose, 4.5 g/L) supplemented with 10%
(vol/vol) fetal bovine serum, 50 μg/ml streptomycin, and
50 U/ml penicillin.
S. typhimurium invasion of human epithelial monolayers
Infection of HCT116 cells was performed by a pre-
viously described method [53]. Bacterial solution (~20
bacteria/epithelial cell) was added and bacterial invasion
was assessed after 1 hour. Cell-associated bacteria,
representing bacteria adhered to and/or internalized
into the monolayers, were released by incubation with
100 μl of 1% Triton X-100 (Sigma). Internalized bacteria
Table 1 Salmonella strains used in this study
Name Description Reference or source
Salmonella SL14028s Wild-type pathogenic Salmonella typhimurium ATCC
SL14028s AvrA- SL14028s without AvrA Constructed in our lab
SL1344 Wild-type Salmonella SL1344 strain Hardt et al.,1997
SL1344 AvrA- SL 1344 mutation without AvrA gene Hardt et al.,1997
PhoPC Non-pathogenic complex regulator mutant derived from SL14028s Miller et al., 1990
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were those obtained from lysis of the epithelial cells
with 1% Triton X-100, 20 min after the addition of gen-
tamicin (50 μg/ml). Gentamicin, an aminoglycoside anti-
biotic, does not permeate eukaryotic plasma membranes
and is therefore cytolytic only to extracellular popula-
tions of bacteria while intracellular bacteria populations
remain viable [67]. For both cell associated and interna-
lized bacteria, 0.9 ml LB broth was then added and each
sample was vigorously mixed and quantitated by plating
for CFU on MacConkey agar medium.
Immunoblotting for epithelial cell signaling
Intestinal epithelial cells were incubated with equal num-
bers of the indicated S. typhimurium strain (about 20 bac-
teria per epithelial cell) for 30 minutes, washed, and
incubated in fresh DMEM for 30 minutes as previously
described [53,68,69]. Cells were rinsed twice in ice-cold
HBSS, lysed in protein lysis buffer (50 mM Tris, pH 6.8,
100 mM dithiothreitol, 2% SDS, 0.1%bromophenol blue,
10% glycerol), and sonicated. Equal amounts of protein
were separated by SDS-polyacrylamide gel electrophoresis,
transferred to nitrocellulose, and immunoblotted with one
of the following primary antibodies: anti-p65 (Santa Cruz
Biotechnology Inc., Santa Cruz, CA, USA), anti-IBa,
anti-JNK, anti-phospho-IBa, anti-phospho-c-JUN (Cell
Signal, Beverly, MA), or anti-b-actin (Sigma-Aldrich, Mil-
waukee, WI, USA) antibodies and visualized by ECL.
Real-time quantitative PCR analysis of the IL-8 mRNA
Total RNA was extracted from epithelial cell monolayers
usingTRIzol reagent (Invitrogen, Carlsbad, CA). RNA
integrity was verified by gel electrophoresis. RNA
reverse transcription was doneusing the iScript cDNA
synthesis kit (Bio-Rad, Hercules, CA)according to the
manufacturer’s directions. The RT cDNA reactionpro-
ducts were subjected to quantitative real-time PCR
usingthe MyiQ single-color real-time PCR detection sys-
tem (Bio-Rad)and iQ SYBR green supermix (Bio-Rad)
according to the manufacturer’sdirections. IL-8 cDNA
was amplified by using primers to thehuman IL-8 gene
that are complementary to regions in exon 1(5’-TGCA-
TAAAGACATACTCCAAACCT) and overlapping the
Table 2 PCR Primers for Salmonella effector proteins
Gene Forward primers Reverse primers Access No.
AvrA 5’GAATGGAAGGCGTTGAATCTGC3’ 5’TTGTGCGCCTTGAGTATGTTTGTAA3’ NP_461786.1
gogB 5’ TTC ATA TTT CCC AGA TAG CTT AG 3’ 5’ TCT TGC CTT ACA TAA ACC ATA A 3’ NP_461519.1
luxR 5’ GAA CTA TAT CGC TCC TCA TGA CA 3’ 5’ TCC CAA AGA ATA GGT GAG TGA TT 3’ YP_002265254.1
luxS 5’ CAC ATC CGC CAT CGC CGC TTT C 3’ 5’ GTT TGC TGG CTT TAT GCG CGA CC 3’ YP_002227567.1
pipB1 5’ AGA ATT GCA GCG GTT AAG TTT AC 3’ 5’ CTG GAG GAT GTC AAC GGG TGT 3’ NP_460061.1
pipB2 5’ ACC TTC ACA ATC CGC CAT A 3’ 5’ TAC GAG TCA GTA AAG GCG ACC AT 3’ NP_461706.1
sifA 5’ TAG GTA TGT GGG TAT GCG GTG GT 3’ 5’ CAA ATG ACG GCC ATG ATT AAG A 3’ NP_460194.1
sifB 5’ CCC TGA GCG GTT ACA ACT C 3’ 5’ CGT CGT CAA TAG CTG TTA CAC CT 3’ NP_460561.1
sipA 5’ TGT TCG GCT ATT ATC AAT CGT CT 3’ 5’ CGC AGC AAT CTT ACG CAC CT 3’ NP_461803.1
sipB 5’ CTG ACT GGG CTG CGG TAT TCG TG 3’ 5’ CTG CGG TGG GAC TTG CGG TAA 3’ NP_461806.1
sipC 5’ GCC TTC AGC ACC GAG TTT G 3’ 5’ ATG TCA CGA CTA AAG CGA ATG AG 3’ NP_461805.1
slrP 5’ GAT ACG CAG AAT ACC CGA CAC CC 3’ 5’ CCG CCA TAA TCA GTT CCG CTA A 3’ NP_459778.1
sopA 5’ ATT CAG ACA CGG CGA TGA TG 3’ 5’ TGG CGT CCG TCA GGT GAT AAG CA 3’ NP_461011.1
sopB 5’ TGA GTA ACC CGA CGG ATA CCA GT 3’ 5’ AGC ATC AGA AGG CGT CTA ACC AC 3’ NP_460064.1
sopD 5’ TTA CTA TCA AGA TGG ACG CTT CT 3’ 5’ GTG CAT TTC CCG TCA CTT 3’ NP_461866.1
sopE2 5’ CGG CGT AAC CTC TTT CAT AAC GA 3’ 5’ AGG GTA GGG CGG TAT TAA CCA GT 3’ NP_460811.1
sptP 5’ AGG CGT CTT CCA GCA TTC TAT TG 3’ 5’ GAT CAC CAG CCG TTA CCG TCT AC 3’ NP_461799.1
spvB 5’ AAC TTA ATC CCT CCG CAA TAT CA 3’ 5’ CGT TCC CGC AAA GCT ACA 3’ NP_490529.1
ssaB 5’ TTT AAA AGG CAT TCC ATT AAT TC 3’ 5’ TTT ATG GTG ATT GCG TAT TAC AT 3’ NP_460358.1
ssaM 5’ ATG GAT TGG GAT CTC ATT ACT GA 3’ 5’ GGA ATA CCC TGG AAC GCT 3’ NP_460378.1
sseF 5’ CGG CAA GTA ATA TAG TCG ATG GT 3’ 5’ AAG GGT GTT AGC GCA GTT AAG A 3’ NP_460369.1
sseG 5’ CCG GAC TTG CGA AAC GAG TG 3’ 5’ CCC ATC CAT ACC GAA GCG AGT AA 3’ NP_460370.1
sseI 5’ TCA TAT TGG AAG CGG ATG TC 3’ 5’ GGC CAT TCA GAT TAC TCA TAC CT 3’ NP_460026.1
sseJ 5’ CAG GAA CAC GCC GAT AAG TTG A 3’ 5’ CCG CCA AAG TAT TGA CCA TAG GA 3’ NP_460590.1
sseL 5’ GAA CGG GAT CAT CAG ATA TAG AC 3’ 5’ CCC AAT AGG ATA GTT TAC CGA 3’ NP_461229.1
sspH2 5’ GGT GGG TCA GCG GGT TAC T 3’ 5’ CCT TTC ATA TTG GAA GCG GAT GT 3’ NP_461184.1
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splice sitebetween exons 3 and 4 (5’-AATTCT-
CAGCCCTCTTCAAAAA). All expressionlevels were
normalized to the GAPDH levels of the same sample,
using forward (5-CTTCACCACCATGGAGAAGGC)
and reverse (5’-GGCATGGACTGTGGTCATGAG)pri-
mers for GAPDH. Percent expression was calculated as
theratio of the normalized value of each sample to that
of thecorresponding untreated control cells. All real-
time PCR reactionswere performed in triplicate. All PCR
primers were designedusing Lasergene software (DNAS-
tar, Madison, WI).
Salmonella-induced human IL-8 secretion
HCT116 cells were cultured in DMEM, followed by
incubation in Salmonella-containing HBSS (1.6 × 1010
bacteria/ml) for 30 min, washed 3 times in HBSS, and
incubated at 37°C for 6 hours. Cell supernatants were
removed and assayed for IL-8 by ELISA in 96-well
plates as described previously [53].
Treatment with JNK inhibitor SP600125
To determine whether the effects of TNF is required for
JNK, cells were treated with a JNK inhibitor SP600125
(EMD Biosciences, San Diego, CA). SP600125 (50 μM)
was added directly to the culture medium one hours
before Salmonella treatment. For Western blot assay,
HCT116 (with SP600125 pretreatment) were incubated
with Salmonella (SP600125 50 μM) 1 hour, washed
three times in HBSS and incubated HBSS (SP600125 50
μM) for 1 hour, then harvested. Levels of indicated pro-
teins were determined by Western blotting as described
above. For Salmonella invasion and IL-8 ELISA:
HCT116 (with SP600125 pretreatment) were incubated
with Salmonella (SP600125 50 μM) 1 hour, washed
three times in HBSS and incubated DMEM for 6 hours.
Statistical analysis
Data are expressed as means ± SD. All statistical tests
were 2-sided. P values of less than .05 were considered
to be statistically significant. Differences between two
samples were analyzed by a Student’s t-test. Statistical
analyses were performed using SAS version 9.2 (SAS
Institute, Inc., Cary, NC).
Results
The alteration of Salmonella effector gene expression
after TNF-a treatment
We first tested whether TNF-a treatment changes the
mRNA expression levels of Salmonella effectors. We
used TNF-a at a concentration of 10 ng/ml, which is
similar to the pathologic concentration in an inflamed
intestine or patient serum [70]. Using RT-PCR, we
investigated the mRNA expression of Salmonella effec-
tors in the pathogenic Salmonella typhimurium SL1344
with or without TNF-a treatment. As shown in Fig. 1A,
SipA was up-regulated by TNF-a, whereas gogB and
spvB were down-regulated by TNF-a exposure (Fig.
1A). We tested 23 Salmonella effectors, those showing
an upregulation of mRNA expression in response to
TNF-aare shown in Fig. 1B and those that were down-
regulated following TNF-a exposure are shown in Fig.
1C. TNF-a significantly upregulated the mRNA expres-
sion of SipA, whereas it down-regulated the mRNA
expression of gogB and spvB. Overall, this PCR data
suggests that certain effectors are responsive to the host
inflammatory factor TNF-a.
Responses to TNF-a treatment in Salmonella strains with
or without AvrA
Our previous studies found that the Salmonella effector
AvrA inhibits the proinflammatory NF-B pathway
(Collier-Hyams et al., 2002) and stabilizes b-catenin and
IBa [71]. We reasoned that the expression levels of
AvrA in the bacterial strains may alter their responses
to TNF-a treatment. Therefore, we tested effector
expression levels in pathogenic Salmonella strains and
corresponding AvrA mutants with or without TNF-a
treatment. SL14028s with AvrA gene expression is
known to express the AvrA protein only at low pH [27].
As shown in Fig. 2, SipA expression was not changed by
TNF-a in SL14028s, whereas SipA mRNA in SL1344
was significantly elevated by TNF-a. PhoPC is a muta-
tion derived from SL1344 [63]. Interestingly, the SipA
mRNA was undetectable in PhoPC.
To confirm that TNF-a pretreatment had no effects
on bacterial growth, we measured the optical density
(O.D.) of the bacteria in LB after TNF-a treatment for
18 hours. Over the still culture period, no significant
difference was observed between the bacterial strain
SL1344 with or without TNF-a pretreatment (Fig. 2B).
Similar results were found in the SL1344 AvrA-strain
with or without TNF-a treatment (Fig. 2C).
In Table 3, we summarize the changes of effector gene
expression after TNF-a 18-hour treatment in Salmo-
nella strains with or without AvrA expression.
Alteration of Salmonella effector proteins after TNF-a
treatment
Effector protein expression may be different from
mRNA levels. We therefore examined strains of Salmo-
nella to determine whether SipA protein levels respond
to TNF-a treatment. As shown in Fig. 3, SipA expres-
sion was elevated by TNF-a in SL14028s and SL1344.
To make sure the difference we observed was not due
to protein loading variation, we stained the membrane
with Ponceau S Red that indicates total protein levels
(Fig. 3B). Relatively equal amounts of proteins in each
lane were visible. We also found that SipA and AvrA
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could not be detected in the AvrA deletion strain
derived from SL14028s (Fig. 3A). Without AvrA,
SL1344 AvrA-did not alter SipA expression after TNF-a
treatment. In addition, we generated an anti-AvrA anti-
body to detect the level of AvrA protein expression.
SL14028s is known to express the AvrA protein only at
low pH [26,27]. Therefore, we did not detect AvrA in
the SL14028s group cultured in LB at pH 7.5. AvrA
expression is high in the SL1344 strain and increased
with TNF-a exposure. Taken together, we found that
TNF-a significantly increased SipA protein expression
in the pathogenic SL14028s and SL1344 strains (Fig.
3C).
TNF-a pretreatment of Salmonella enhances invasion of
host cells
We then examined whether pre-treating Salmonella
with TNF-a contributes to the physiological function of
Figure 1 Levels of effector gene expression determined by RT-PCR in Salmonella SL1344. (A) Representative PCR results for effector mRNA
expression. Mdh was used as the internal control. Control: Salmonella without treatment; TNF-a: Salmonella treated with TNF-a. (B) and (C) The
relative intensity of PCR bands (Control vs. TNF-a-pretreated Salmonella). There were 3 repeated experiments performed in all controls and TNF-
a treated groups. First, the densitometry value of each indicated effector gene was divided by the value for the Mdh band. Next, the obtained
values were compared with the corresponding control values. The relative fold changes are shown in Figure 1B and 1C with the control group
value set as “1” and compared to the TNF-a treated groups. Data are reported as the mean ± SD of three independent experiments. *P < 0.05
was considered significant.
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Salmonella, such as invasion. To determine whether
TNF-a contributed to Salmonella invasion, we counted
the number of Salmonella invading the human intestinal
epithelial HCT116 cells. We found that TNF-a pretreat-
ment of Salmonella increased the amount of interna-
lized bacteria in epithelial cells versus untreated
Salmonella SL1344 (Fig. 4A). In the Salmonella SL1344
AvrA-strain, we also found that TNF-a enhanced bac-
terial invasion of host cells (Fig.4B). Moreover, we
examined the number of cell-associated bacteria, includ-
ing bacteria adhered to and/or internalized into the
epithelial monolayers. Our data showed no significant
difference of Salmonella associated with epithelial cells
with or without TNF-a pretreatment (Fig. 4C SL1344
and Fig. 4D SL1344 AvrA-). Furthermore, we used a
JNK inhibitor, SP600125, to treat cells in order to con-
firm the enhanced bacterial invasion is related to the
JNK pathway. Significantly less number of invaded bac-
teria was found in SL14028S group with SP600125 com-
pared to the no-inhibitor groups (P < 0.05 Fig. 4E).
However, invaded bacterial numbers in the TNF pre-
treatment group and non-TNF treatment group were
still significantly different (P < 0.05 Fig. 4D), suggesting
that SP600125 could not block the effect of TNF-
pretreated Salmonella in enhancing invasion. These
in vitro data indicates that TNF-a pretreatment changes
the ability of Salmonella to internalize into host cells.
TNF-a pretreated Salmonella changes the host response
We further hypothesized that TNF-a treatment changes
Salmonella effector protein expression, thus altering the
host’s inflammatory responses. The c-Jun N-terminal
kinase (JNK) pathway is known to be regulated by the
Salmonella effector AvrA [29,71]. Salmonella increases
JNK phosphorylation [29]. We tested for the alteration of
these two pathways as read-outs of inflammatory
responses from host cells. We found that TNF-a
pretreated Salmonella SL1344 could enhance c-JUN, p-c-
JUN, and p-JNK expression in HCT116 cells (Fig. 5A).
Statistical data further showed a significant difference in
expression of p-c-JUN and p-JNK induced by Salmonella
with or without TNF-a treatment (Fig. 5B and 5C).
Moreover, we confirm the role of JNK pathway with a
JNK inhibitor, SP600125. Inhibitor treatment blocked the
enhancement of both p-c-JUN and p-JNK induced by
Salmonella with or without TNF-a (Fig. 5D). In addition,
we tested the activity of AP-1, a transcription factor
which is a heterodimeric protein associated with c-Jun
[72]. However, we did not find the difference in induction
of AP-1 activity by Salmonella without TNF or with
TNF-pretreatment (data not shown).
Figure 2 The effects of AvrA deletion on effector expression.
SipA mRNA expression in the indicated Salmonella strains was
determined by PCR. The relative intensity of the PCR bands was
analyzed. Control: Salmonella without treatment; TNF-a: Salmonella
treated with TNF-a. The data are reported as the mean ± SD of
three independent experiments. *P < 0.05 was considered
significant.
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IL-8 mRNA and protein levels in intestinal epithelial cells
induced by Salmonella with or without TNF-a treatment
Cytokine IL-8 expression and secretion are common
readouts for inflammatory responses in the host cells
[73]. It is known that pathogenic Salmonella increases
IL-8 through both transcriptional regulation and protein
expression levels [58,71,73,74]. We reasoned that expo-
sure to TNF-a makes pathogenic Salmonella more
aggressive, inducing more severe inflammatory
responses as compared to Salmonella without TNF-a
treatment. We assessed the effect of TNF-a exposed
Salmonella on IL-8 mRNA expression in human intest-
inal HCT116 cells. IL-8 mRNA real-time PCR showed
that HCT116 cells significantly increased the level of IL-
8 mRNA expression after TNF-a pretreated Salmonella
colonization (Fig. 6A). In contrast, cells colonized with
untreated Salmonella expressed less inflammatory IL-8
mRNA (Fig. 6A). Both pathogenic SL14028s and SL1344
had similar trends: TNF-a pretreated Salmonella
induced significantly higher amounts of IL-8 mRNA,
over 2.5 folds as compared to untreated Salmonella (Fig.
6A). Furthermore, we examined IL-8 protein secretion
into the cell media caused by bacterial infection. As
shown in Fig. 6B, an increase in IL-8 protein secretion
was detected in the cell media after TNF-a pretreated
Salmonella SL14028s colonization for 6 hours. In con-
trast, less IL-8 protein secretion was induced by
untreated Salmonella SL14028s colonization (Fig. 6B).
SL1344 had similar trends: TNF-a pretreatment induced
significantly higher amounts of IL-8 secretion compared
to untreated Salmonella (Fig. 6A). Overall, there is a sig-
nificant difference of IL-8 secretion in cells colonized
with Salmonella strains with or without TNF-a pretreat-
ment. A possibility of the increased IL-8 could be due to
the enhanced internalized bacteria after TNF pretreat-
ment. We further tested the relationship between the
bacterial loading, intercellular bacterial number and IL-8
secretion. However, we did not find that IL-8 secretion
linearly related to the invaded bacterial numbers in the
cells (data not shown). The enhanced bacterial invasion
by TNF treatment and the increased IL-8 could be two
different physiological effects in the host cells. Increased
bacterial invasion is not necessary to induce increased
IL-8 secretion.
Table 3 Bacteria effector gene expression after 18-hour treatment with TNF-a in Salmonella strains with or without
AvrA
SB1117 (AvrA-) SB300 (with AvrA) phopC SL14028s (AvrA-) SL14028s (with AvrA)
SipA ↓ ↑* ND ↑ ↓
SipB ↑ ↑ ↓ ↓ ↑
SipC ↑ ↑ ND ↓ ND
sopA ↓ ↑ ↓ ↓ ↓
sopB ↓ ↓ ↓ ↑ ↑
sopD ↑ ↓ ↓ ↓ ↓
sopE2 ↑ ↑ ND ↓
sptP ↑ ↑ ↓ ND ↑
gogB ↓ ↓# ↓ ↑ ↓
pipB1 ↑ ↓ ↑ ↑ ND
pipB2 ↑ ↑ ↑ ↑ ↓
sifA ↓ ↓ ↓ ↑ ↓
sifB ↓ ↓ ↓ ↑ ↓
ssaM ↑ ↓ ↓ ↑ ND
ssaB ↓ ND ↓ ↑ ↓
spvB ↓ ↓# ↑ ND ↓
sseF ↑ ↑ ↓ ↑ ↓
sseG ↑ ↓ ↓ ↓ ↑
sseI ↑ ↓ ↓ ↑ ↑
sseJ ↓ ↑ ↑ ↑ ↑
sseL ↑ ↓ ↓ ↑ ↓
sspH2 ND ↓ ↓ ↑ ↓
slrP ↓ ↑ ↓ ND ↑
luxS ↓ ↑ ↑ ↓ ↑
* P < 0.05; # P < 0.01. ND: not detectable by PCR.
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To confirm the effect of TNF-pretreated Salmonella
on IL-8 secretion is through the JNK pathway, we
further used the inhibitor SP600125 to treat cells, signif-
icant less IL-8 was found in the SL14028S Salmonella
with SP600125 group compared to the non-inhibitor
group (Fig. 6C P < 0.03). SP600125 treatment was able
to decrease the IL-8 secretion significantly in the
SL14028 + TNF group v.s. the SP600125 + SL14028 +
TNF group (Fig. 6C P = 0.017). There was significant
difference in Sl14028S with or without TNF pretreat-
ment (Fig. 6C P < 0.05). However, the difference
Figure 3 SipA and AvrA protein expression. (A) Western blot
assay for the expression of SipA and AvrA. (B) Relative protein band
intensity in Ponceau S Red staining. Data are reported as
representative results from three independent experiments. (C) The
relative intensity of the Western blot bands. The data are reported
as the mean ± SD of three independent experiments. *P < 0.05 was
considered significant.
Figure 4 TNF-a pretreatment of Salmonella contributes to
enhanced bacterial invasion in human intestinal epithelial
HCT116 cells. (A) and (B) Number of internalized Salmonella (A:
SL1344; B: SL1344 AvrA-) in the HCT116 cells. (C) and (D) Number of
Salmonella associated with HCT116 cells. C: SL1344; D: SL1344 AvrA-.
(E) Number of internalized Salmonella in the HCT116 cells with a
JNK inhibitor SP600125 (50 μM) pretreatment. HCT116 cells were
stimulated with Salmonella with or without TNF-a pretreatment for
30 min, washed, and incubated in fresh DMEM for 30 min. For both
cell associated and internalized bacteria, 0.9 ml LB broth was then
added and each sample was vigorously mixed and quantitated by
plating for CFU on MacConkey agar medium. The mean ± SD is
from three replicate experiments.
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between TNF pretreatment or no-TNF treatment was
abolished after SP600125 pretreatment (Fig. 6C). Taken
together, these IL-8 data indicate that TNF-a pretreated
Salmonella stimulated more inflammatory responses in
the intestinal epithelial cells through the JNK pathway.
Discussion
The aim of this study was to determine the effect of
TNF-a on Salmonella effector expression and the ability
of TNF-a pretreated Salmonella to induce inflammatory
responses in host epithelial cells. We investigated the
regulation of Salmonella effectors in a variety of con-
texts, including mRNA expression, protein expression,
and host-bacteria interaction Furthermore, we explored
the response of human intestinal cells to TNF-a pre-
treated Salmonella. Bacterial invasion was enhanced in
cells colonized with TNF-a pretreated Salmonella. Sal-
monella strains with TNF-a pretreatment induced
higher proinflammatory responses compared to
untreated Salmonella. Overall, our data show that TNF-
a exposure makes Salmonella more virulent and
enhances inflammation in host intestinal cells. This
study provides a new insight into the Salmonella-host
interaction in intestinal inflammation and infection.
Our study demonstrates that Salmonella senses the
host inflammatory factor TNF-a and responds by chan-
ging its effector protein expression and enhancing its
virulence, such as invasion. However, it is unknown how
Salmonella senses TNF-a in the environment and
whether Salmonella has a receptor for TNF-a. Recent
findings have begun to reveal the molecular mechanisms
by which bacteria can sense small innate immune mole-
cules and modulate virulence gene expression. Wu et al.
demonstrated that Pseudomonas aeruginosa recognizes
host immune activation and responds by enhancing
their virulence phenotype [75]. Also in Pseudomonas,
Figure 5 JNK pathway is activated by S. typhimurium with or without TNF-a pretreatment. A. The expression level of proteins associated
with the JNK pathway in intestinal epithelial cells colonized with Salmonella. Intestinal epithelial cells were incubated with an equal number of
the indicated S. typhimurium with or without TNF-a pretreatment. Epithelial cells were collected. Cell lysates were immunoblotted with the
indicated antibodies. b-actin is an internal control for the Western blot. The data are reported as the mean ± SD of three independent
experiments. (B) (C) Relative intensity of Western blot bands. Salmonella exposed to TNF-a induced higher activity of JNK pathway with
enhanced p-JNK and p-c-Jun in the host cells. The data are reported as mean ± SD of three independent experiments. *P < 0.05 was considered
significant. (D). The expression level of proteins associated with the JNK pathway in intestinal epithelial cells colonized with Salmonella. HCT116
cells were pretreated with a JNK inhibitor SP600125 (50 μM).
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Zaborina et al. showed dynorphin regulation of bacterial
pathogenesis and cross-signaling between quorum sen-
sing and quinolone signaling [76]. Norepinephrine mod-
ulates interactions between enterohemorrhagic
Escherichia coli (EHEC) and the colonic epithelium by
increasing bacterial adherence to the colonic mucosa
[77]. EHEC uses a QS regulatory system to “sense” that
it is within the intestine and then activates genes essen-
tial for intestinal colonization [13]. The QS system used
by EHEC is known as the LuxS/autoinducer 2 (AI-2)
system extensively involved in interspecies communica-
tion [13]. Given that eukaryotic cell-to-cell signaling
typically occurs through hormones, and bacterial cell-to-
cell signaling occurs through QS, QS may be used as a
“language” by which bacteria and host cells communi-
cate [13]. In S. typhimurium, the PhoQ sensor kinase is
activated by host antimicrobial peptides. PhoQ then pro-
motes the expression of virulence genes through a phos-
phorelay cascade [78]. However, it is still unknown how
pathogenic Salmonella senses TNF-a, thus changing the
expression of the bacterial effectors. Studies in Pseudo-
monas raise the possibility that TNF-a sensors or recep-
tors for TNF-a are encoded for in the prokaryotic
genome. Further studies on the Salmonella quorum sen-
sing system and effector regulation will provide insights
into this powerful and effective bacteria-host interaction.
Our data demonstrate that TNF-a exposure increases
the expression of the Salmonella effector SipA. SipA
contributes significantly to Salmonella host cell invasion
in vitro and to Salmonella enterocolitis in vivo
[35,41,79]. SipA also plays key role in maximizing pro-
inflammatory responses [41]. Our bacterial invasion
study further showed that cells colonized with TNF-a
pretreated Salmonella had more internalized Salmonella.
Moreover, Salmonella strains with TNF-a pretreatment
induced higher proinflammatory responses, such as the
activation of JNK and elevation of IL-8, compared to the
Salmonella strains without TNF-a exposure. This obser-
vation is correlated with the enhanced expression of
SipA in Salmonella exposed to TNF-a.
At the mRNA level SL1344 expressing AvrA has a sig-
nificant ability to modify SipA in response to TNF-a,
whereas SL14028s is less responsive (Fig.2A). We also
found that an AvrA knockout strain derived from
SL14028s had significantly decreased levels of SipA
mRNA and protein. Salmonella SL14028s is known to
be deficient in AvrA expression. AvrA protein expres-
sion was only detectable when SL14028s was cultured in
low pH media [25-27]. The status of the effector AvrA
may alter the expression of other effectors and the capa-
city of bacteria to induce host inflammation. Other fac-
tors in the environment may also contribute to the
expression changes of Salmonella effectors. Although
AvrA is known to regulate diverse bacteria-host
Figure 6 TNF pretreatment of Salmonella contributes to
enhanced IL-8 mRNA and proteins in human intestinal
epithelial cells. Cells were cultured in DMEM, followed by
Salmonella-containing HBSS for 30 min, washed 3 times in HBSS,
and incubated at 37°C for 6 hours. Total RNA was extracted for real-
time PCR. Cell supernatants were removed and assayed for IL-8 by
ELISA. (A) IL-8 mRNA levels in the HCT116 cells after colonization
with TNF-pretreated Salmonella. (B) IL-8 protein secreted into the
cell culture media in the HCT116 cells after Salmonella infection. (C)
IL-8 protein secreted into the cell culture media in the HCT116 cells
after Salmonella infection. HCT116 cells were pretreated with a JNK
inhibitor SP600125 (50 μM). In a single experiment, samples were
assayed in triplicate. The data are reported as mean ± SD of three
independent experiments. *P < 0.05 was considered significant.
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interactions [28,29,71,80], the synergistic regulation of
AvrA and other Salmonella effectors in response to the
inflammatory status of the host cells remains unknown.
Further investigations on the interaction of AvrA and its
fellow effectors will help us to understand the network
of Salmonella effectors in epithelial cell-bacteria cross-
talk.
TNF-a exposure decreased the mRNA expression of
SPI-2 effectors Gog B and SpVB, which are known to
promote bacterial replication and systemic spread
[19,20,22]. We did not examine the protein expression
of these two proteins, while the cell culture system lim-
ited investigation into the physiologic relevance of the
reduction of Gog B and SpVB. Long-term bacterial
replication and systematic spread need to be examined
in an in vivo model.
In summary, our current study answers the fundamen-
tal question of whether TNF-a expressed from host cells
can change the expression level of Salmonella effectors,
such as SipA, gogB, and spvB. Salmonella exposed to
TNF-a induced more bacterial internalization, higher
activity of JNK pathway with enhanced p-JNK and p-c-
Jun in the host cells. As a consequence of the activation
of the JNK pathway, the expression of inflammatory
cytokines, such as IL-8, is higher in cells colonized with
TNF-a pretreated Salmonella. Overall, Salmonella
exposed to TNF-a caused enhanced inflammation in
intestinal epithelial cells. We postulate that chronic
inflammation with elevated TNF-a in host cells may
change the behavior of pathogenic bacterial effectors
and may make pathogens more virulent.
Conclusions
We found that TNF-a treatment modulated effector
expression in a differential manner. The expression of
effector SipA was increased after TNF-a exposure in
pathogenic Salmonella. Enhanced bacteria internaliza-
tion and more severe inflammatory responses of intest-
inal epithelial cells were found after Salmonella strains
were exposed to TNF-a. Activation of the JNK pathway
significantly elevates and enhances inflammation in
intestinal epithelial cells. As a consequence, the expres-
sion of inflammatory cytokines, such as IL-8, is high in
cells colonized with TNF-a pretreated Salmonella. Our
studies provide new insights into host factor TNF-a reg-
ulation of Salmonella effector expression in bacterial
invasion and inflammatory responses.
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